Published in Prostate Cancer Prostatic Dis on August 24, 2010
Obesity and cancer: mechanistic insights from transdisciplinary studies. Endocr Relat Cancer (2015) 0.96
Carbohydrate restriction and lactate transporter inhibition in a mouse xenograft model of human prostate cancer. BJU Int (2012) 0.95
Roles of caloric restriction, ketogenic diet and intermittent fasting during initiation, progression and metastasis of cancer in animal models: a systematic review and meta-analysis. PLoS One (2014) 0.92
The effect of carbohydrate restriction on prostate cancer tumor growth in a castrate mouse xenograft model. Prostate (2012) 0.90
Weight cycling and cancer: weighing the evidence of intermittent caloric restriction and cancer risk. Cancer Prev Res (Phila) (2011) 0.89
A high-fat diet containing whole walnuts (Juglans regia) reduces tumour size and growth along with plasma insulin-like growth factor 1 in the transgenic adenocarcinoma of the mouse prostate model. Br J Nutr (2012) 0.88
Resveratrol worsens survival in SCID mice with prostate cancer xenografts in a cell-line specific manner, through paradoxical effects on oncogenic pathways. Prostate (2012) 0.84
Annual fasting; the early calories restriction for cancer prevention. Bioimpacts (2012) 0.83
Fish oil slows prostate cancer xenograft growth relative to other dietary fats and is associated with decreased mitochondrial and insulin pathway gene expression. Prostate Cancer Prostatic Dis (2013) 0.82
In vitro and in vivo evaluation of resveratrol and 3,5-dihydroxy-4'-acetoxy-trans-stilbene in the treatment of human prostate carcinoma and melanoma. J Surg Res (2012) 0.81
Ramadan Fasting and Patients with Cancer: State-of-the-Art and Future Prospects. Front Oncol (2016) 0.75
Could Intermittent Energy Restriction and Intermittent Fasting Reduce Rates of Cancer in Obese, Overweight, and Normal-Weight Subjects? A Summary of Evidence. Adv Nutr (2016) 0.75
Role of intermittent fasting on improving health and reducing diseases. Int J Health Sci (Qassim) (2014) 0.75
Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet (1998) 10.11
Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science (1998) 6.50
Insulin-like growth factor-I receptor signaling and resistance to trastuzumab (Herceptin). J Natl Cancer Inst (2001) 5.24
Anastrozole is superior to tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: results of a North American multicenter randomized trial. Arimidex Study Group. J Clin Oncol (2000) 4.03
Emerging role of insulin-like growth factor receptor inhibitors in oncology: early clinical trial results and future directions. Oncogene (2009) 2.17
Molecular cloning and further characterization of a probable plant vacuolar sorting receptor. Plant Physiol (1997) 2.16
Long-term effects of insulin glargine on the risk of breast cancer. Diabetologia (2011) 2.15
Plasma insulin-like growth factor (IGF) I, IGF-binding protein 3, and mammographic density. Cancer Res (2000) 2.10
Biogenesis of the protein storage vacuole crystalloid. J Cell Biol (2000) 1.67
Chloroplast fructose-1,6-bisphosphatase: the product of a mosaic gene. Nucleic Acids Res (1988) 1.58
Adherence of Vibrio cholerae to cultured differentiated human intestinal cells: an in vitro colonization model. Infect Immun (1997) 1.55
Novel promoter polymorphism in insulin-like growth factor-binding protein-3: correlation with serum levels and interaction with known regulators. J Clin Endocrinol Metab (2001) 1.53
pho3: a phosphorus-deficient mutant of Arabidopsis thaliana (L.) Heynh. Planta (2001) 1.50
California as a model. J Clin Oncol (2001) 1.49
Diet and tumor LKB1 expression interact to determine sensitivity to anti-neoplastic effects of metformin in vivo. Oncogene (2010) 1.47
In vivo progression of LAPC-9 and LNCaP prostate cancer models to androgen independence is associated with increased expression of insulin-like growth factor I (IGF-I) and IGF-I receptor (IGF-IR). Cancer Res (2001) 1.46
The protein storage vacuole: a unique compound organelle. J Cell Biol (2001) 1.44
Molecular-orbital studies of intermolecular interaction energies. II. Approximations concerned with Coulomb interactions and comparison of the two London schemes. J Chem Phys (1967) 1.38
The extracellular calcium-sensing receptor: its role in health and disease. Annu Rev Med (1998) 1.36
Calcium-ion-sensing cell-surface receptors. N Engl J Med (1995) 1.35
Genetic and nongenetic factors associated with variation of plasma levels of insulin-like growth factor-I and insulin-like growth factor-binding protein-3 in healthy premenopausal women. Cancer Epidemiol Biomarkers Prev (2001) 1.35
Obstructive uropathy secondary to ureteroinguinal herniation. Rev Urol (2001) 1.33
Changes of knowledge, attitudes, beliefs, and preference of bar owner and staff in response to a smoke-free bar law. Tob Control (2004) 1.29
Milk intake, circulating levels of insulin-like growth factor-I, and risk of colorectal cancer in men. J Natl Cancer Inst (2001) 1.29
An overview of the vaccine adverse event reporting system (VAERS) as a surveillance system. VAERS Working Group. Vaccine (1999) 1.23
Insulin-like growth factor-binding protein-3 inhibition of prostate cancer growth involves suppression of angiogenesis. Oncogene (2006) 1.22
Genetic factors related to racial variation in plasma levels of insulin-like growth factor-1: implications for premenopausal breast cancer risk. Mol Genet Metab (2001) 1.22
Randomized phase II study of two doses of gefitinib in hormone-refractory prostate cancer: a trial of the National Cancer Institute of Canada-Clinical Trials Group. J Clin Oncol (2005) 1.21
Metformin does not affect risk of biochemical recurrence following radical prostatectomy: results from the SEARCH database. Prostate Cancer Prostatic Dis (2013) 1.20
Small decreases in SBPase cause a linear decline in the apparent RuBP regeneration rate, but do not affect Rubisco carboxylation capacity. J Exp Bot (2001) 1.16
cDNA and gene sequences of wheat chloroplast sedoheptulose-1,7-bisphosphatase reveal homology with fructose-1,6-bisphosphatases. Eur J Biochem (1992) 1.15
Arabidopsis thaliana carbonic anhydrase: cDNA sequence and effect of CO2 on mRNA levels. Plant Mol Biol (1992) 1.13
Anti-HIV seroprevalence in California blood and plasma donors. West J Med (1988) 1.12
Regulation of intestinal goblet cell secretion. III. Isolated intestinal epithelium. Am J Physiol (1984) 1.10
Race is associated with discontinuation of active surveillance of low-risk prostate cancer: results from the Duke Prostate Center. Prostate Cancer Prostatic Dis (2012) 1.10
Metformin enhances the antiproliferative and apoptotic effect of bicalutamide in prostate cancer. Prostate Cancer Prostatic Dis (2012) 1.09
Body size and breast cancer prognosis: a statistical explanation of the discrepancies. Cancer Res (1989) 1.08
Expression of insulin-like growth factor receptor, IGF-1, and IGF-2 in primary and metastatic osteosarcoma. J Surg Oncol (1998) 1.07
Race and prostate weight as independent predictors for biochemical recurrence after radical prostatectomy. Prostate Cancer Prostatic Dis (2008) 1.07
Insulin-like growth factor binding protein-3 induces apoptosis in MCF7 breast cancer cells. Biochem Biophys Res Commun (1997) 1.06
Insulin-like growth factors and prostate cancer: a population-based case-control study in China. Cancer Epidemiol Biomarkers Prev (2001) 1.06
Photosynthetic capacity is differentially affected by reductions in sedoheptulose-1,7-bisphosphatase activity during leaf development in transgenic tobacco plants. Plant Physiol (2001) 1.05
Computer modelling and experimental evidence for two steady states in the photosynthetic Calvin cycle. Eur J Biochem (2001) 1.05
Insulin-like growth factor 1 (IGF-1) receptors, IGF-1, and IGF-2 are expressed in primary human sarcomas. Cancer Res (1995) 1.04
Characterisation of a glycine to valine substitution at amino acid position 910 of the triple helical region of type III collagen in a patient with Ehlers-Danlos syndrome type IV. J Med Genet (1991) 1.03
Prostate biopsies from black men express higher levels of aggressive disease biomarkers than prostate biopsies from white men. Prostate Cancer Prostatic Dis (2011) 1.03
Reduced growth of human breast cancer xenografts in hosts homozygous for the lit mutation. Cancer Res (1996) 1.01
Expression, purification and characterization of a mouse-human chimeric antibody and chimeric Fab' fragment. Biochem J (1992) 1.01
The coding sequence for sedoheptulose-1,7-bisphosphatase detects multiple homologues in wheat genomic DNA. Theor Appl Genet (1992) 1.00
The influence of hepatic function on prostate cancer outcomes after radical prostatectomy. Prostate Cancer Prostatic Dis (2010) 1.00
A prospective study of plasma levels of insulin-like growth factor I (IGF-I) and IGF-binding protein-3, and colorectal cancer risk among men. Growth Horm IGF Res (2000) 1.00
Somatostatin analogue octreotide enhances the antineoplastic effects of tamoxifen and ovariectomy on 7,12-dimethylbenz(alpha)anthracene-induced rat mammary carcinomas. Cancer Res (1994) 0.99
Estradiol and antiestrogens regulate a growth inhibitory insulin-like growth factor binding protein 3 autocrine loop in human breast cancer cells. J Biol Chem (1996) 0.97
Silencing of the mammary-derived growth inhibitor (MDGI) gene in breast neoplasms is associated with epigenetic changes. Cancer Res (1996) 0.97
Diabetes and prostate cancer risk in the REDUCE trial. Prostate Cancer Prostatic Dis (2011) 0.97
Enhancement of tamoxifen-induced suppression of insulin-like growth factor I gene expression and serum level by a somatostatin analogue. Biochem Biophys Res Commun (1994) 0.96
Low dose octreotide and tamoxifen in the treatment of adenocarcinoma of the pancreas. Cancer (1995) 0.95
The effect of race on the discriminatory accuracy of models to predict biochemical recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases. Prostate Cancer Prostatic Dis (2009) 0.95
Silibinin up-regulates insulin-like growth factor-binding protein 3 expression and inhibits proliferation of androgen-independent prostate cancer cells. Cancer Res (2000) 0.95
Tissue-specific targeting of the pthrp gene: the generation of mice with floxed alleles. Endocrinology (2001) 0.95
Insulin, glucose and the increased risk of cancer in patients with type 2 diabetes. Diabetologia (2010) 0.95
Tumor suppressor activity of the gene encoding mammary-derived growth inhibitor. Cancer Res (1995) 0.94
Isolation of a cDNA clone for the human muscle specific carbonic anhydrase, CAIII. Ann Hum Genet (1985) 0.94
Vitamin D receptor gene polymorphisms, insulin-like growth factors, and prostate cancer risk: a population-based case-control study in China. Cancer Res (2001) 0.94
Effect of cyclosporine on conjunctival mucin in a canine keratoconjunctivitis sicca model. Invest Ophthalmol Vis Sci (2001) 0.93
A 27-bp deletion from one allele of the type III collagen gene (COL3A1) in a large family with Ehlers-Danlos syndrome type IV. Hum Genet (1992) 0.93
Predictive value of digital rectal examination for prostate cancer detection is modified by obesity. Prostate Cancer Prostatic Dis (2011) 0.93
In vivo inhibition of insulin-like growth factor I gene expression by tamoxifen. Cancer Res (1993) 0.93
H19 sense and antisense transgenes modify insulin-like growth factor-II mRNA levels. Eur J Biochem (2000) 0.92
Preoperative weight change and risk of adverse outcome following radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital database. Prostate Cancer Prostatic Dis (2011) 0.92
Conventional calcium channel mediates asynchronous acetylcholine release by motor nerve impulses. Nature (1977) 0.91
Decreased SBPase activity alters growth and development in transgenic tobacco plants. Plant Cell Environ (2006) 0.90
Bioassay of 1,25-dihydroxyvitamin D in human plasma purified by partition, alkaline extraction, and high-pressure chromatography. Anal Biochem (1980) 0.90
Insulin-like growth factor I (IGF-I), IGF-binding protein-3 and prostate cancer risk: epidemiological studies. Growth Horm IGF Res (2000) 0.90
Insulin-like growth factor I (IGF-I), IGF-binding protein-3 and the risk of colorectal adenoma and cancer in the Nurses' Health Study. Growth Horm IGF Res (2000) 0.89
Aneurysm formation in expanded polytetrafluoroethylene prostheses. Surgery (1976) 0.88
Establishment and characterization of a new human prostatic carcinoma cell line (DuPro-1). J Urol (1991) 0.87
Impact of nerve sparing on surgical margins and biochemical recurrence: results from the SEARCH database. Prostate Cancer Prostatic Dis (2008) 0.87
Antiproliferative action of tumor necrosis factor-alpha on MCF-7 breastcancer cells is associated with increased insulin-like growth factor binding protein-3 accumulation. Int J Oncol (1998) 0.87
Castration-induced apoptosis in the rat ventral prostate is associated with increased expression of genes encoding insulin-like growth factor binding proteins 2,3,4 and 5. Endocrinology (1998) 0.87
Insulin-like growth factors and mammographic density. Growth Horm IGF Res (2000) 0.87
Co-targeting IGF-1R and c-kit: synergistic inhibition of proliferation and induction of apoptosis in H 209 small cell lung cancer cells. Br J Cancer (2004) 0.87
Molecular cloning of the Arabidopsis thaliana sedoheptulose-1,7-biphosphatase gene and expression studies in wheat and Arabidopsis thaliana. Plant Mol Biol (1994) 0.87
Prostate cancer risk in men with prostate and breast cancer family history: results from the REDUCE study (R1). J Intern Med (2012) 0.87
Colonial opacity variations among the choleragenic vibrios. Microbiology (1997) 0.87
Complete coding sequence of wheat phosphoribulokinase: developmental and light-dependent expression of the mRNA. Mol Gen Genet (1989) 0.86
HT29-18N2 differentiation in a protein-free medium. In Vitro Cell Dev Biol Anim (1995) 0.86
An automated, handheld biosensor for aflatoxin. Biosens Bioelectron (2000) 0.86
Effective temperature in relaxation of Coulomb glasses. Phys Rev Lett (2008) 0.86
Regulation of insulin-like growth factor I receptor expression by the pure antiestrogen ICI 182780. Clin Cancer Res (1996) 0.86
Extraosseous Ewing's sarcoma. Can Assoc Radiol J (1995) 0.86
Regulation of insulin-like growth factor (IGF) II and IGF binding protein 3 autocrine loop in human PC-3 prostate cancer cells by vitamin D metabolite 1,25(OH)2D3 and its analog EB1089. Int J Oncol (1998) 0.85
The role of the primary care physician in tobacco use prevention and cessation. CA Cancer J Clin (1995) 0.85
Sensing of extracellular Ca2+ by parathyroid and kidney cells: cloning and characterization of an extracellular Ca(2+)-sensing receptor. Am J Kidney Dis (1995) 0.85
The ability of suramin to block CD4-gp120 binding is reversed in the presence of albumin. Antimicrob Agents Chemother (1991) 0.85
The international study of insulin and cancer. Lancet (2010) 0.85
Insulin-like growth factor I gene expression in the uterus is stimulated by tamoxifen and inhibited by the pure antiestrogen ICI 182780. Cancer Res (1993) 0.84
Exercise therapy across the prostate cancer continuum. Prostate Cancer Prostatic Dis (2009) 0.84